Can the "happy molecule" serotonin tag proteins? Researchers build a new tool to track them
Shanghai Jiao Tong University Journal Center
image: Structural characterization of 5-PT
Credit: XIAO Shuyu, TULAMATI Aziguli, YANG Yan, ZHANG Zhigang, YANG Xiaomei, DU Chang, ZHANG Xueli.
5-hydroxytryptamine (5-HT) is a neurotransmitter synthesized by serotonergic neurons in the brain and by enterochromaffin cells.
Researchers from Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, led by ZHANG Xueli, found that by using the synthesized 5-PT, multiple serotonylated proteins are enriched in various cell types.
Bioinformatics analysis indicated that TGM2 and SLC6A4 were widely expressed in various normal tissues and across pan-cancer tissues.
The work was done mainly in animal models and cultured cells, so the results still need confirmation in patients.
The authors write: "A research system for identifying serotonylated proteins has been successfully established, providing a relatively simple and efficient method for studying protein serotonylation."
It acts through HTR family receptors, for example activating PI3K/AKT/mTOR signaling via HTR2B in pancreatic cancer cells, or through post-translational modification: transglutaminase 2 (TGM2) covalently attaches 5-HT to glutamine residues of target proteins, a process termed serotonylation. Identifying serotonylated proteins remains challenging, because existing approaches suit abundant, readily purified proteins, while immunoprecipitation with anti-5-HT-BSA antibodies requires extensive preliminary work. This study chemically synthesized 5-PT (5-propargyltryptamide), an alkynylated 5-HT derivative that can be coupled to functional groups by click chemistry to label serotonylated proteins. The resulting system is more compatible with biological macromolecules, reacts under mild conditions and is more specific, reducing non-specific modification and enabling direct, efficient characterization of serotonylated proteins. It offers a practical tool for discovering new serotonylated proteins and for studying the mechanisms and treatment of related diseases.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.